• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹膜透析液中化学物质和迁移性塑料的检测

Detections of Chemicals and Migratory Plastics in Peritoneal Dialysis Fluids.

作者信息

Panda Sanjay Kumar, Maloth Rama Krishna, Upadyayalu Vijayasarthi, Mishra Ankita, Noronha Santosh

机构信息

Department of Nephrology, Base Hospital Delhi Cantt, New Delhi, India.

Department of Analytical and Structural Chemistry, CSIR-Indian Institute of Chemical Technology, Hyderabad, Tarnaka, India.

出版信息

Indian J Nephrol. 2025 Jan-Feb;35(1):34-39. doi: 10.25259/ijn_515_23. Epub 2024 Jul 1.

DOI:10.25259/ijn_515_23
PMID:39872250
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11763172/
Abstract

BACKGROUND

Peritoneal dialysis (PD) is an important modality of renal replacement therapy (RRT). Peritonitis and ultrafiltration failure are complications that have a long-term impact on PD patients. Besides touch contamination, procedural errors and clinical reasons of peritonitis, contaminants, and constituents of peritoneal dialysis fluids (PDFs) have been implicated in causing peritonitis and ultrafiltration failure. This study was aimed to test the PDFs in India for the presence of migratory plastics.

MATERIALS AND METHODS

PDFs from the two manufacturers in India were tested using liquid chromatography mass spectrometry (LCMS) and gas chromatography mass spectrometry (GCMS) with headspace analysis (volatile compounds) and pyrolysis of plastics (polymer compounds). The storage conditions and handling were uniform.

RESULTS

The results revealed impurities of acetate compounds and aldehyde derivatives of glucose degradation products (GDPs) with contaminants and leachable plastics. There were high levels of GDP derivative in the form of 5-hydroxymethylfurfural compounds (5-HMF). The analysis revealed the presence of plastic softeners in very high concentrations.

CONCLUSION

The study unmasks the presence of chemicals and GDPs that can be implicated in pathogenesis of sterile peritonitis and ultrafiltration failure. The study demonstrated the presence of leachable plastics. In conclusion, LCMS and GCMS studies can be used to test PDFs for unwanted chemicals prior to human use.

摘要

背景

腹膜透析(PD)是肾脏替代治疗(RRT)的一种重要方式。腹膜炎和超滤失败是对腹膜透析患者有长期影响的并发症。除了接触污染、操作失误以及腹膜炎的临床原因外,腹膜透析液(PDFs)中的污染物和成分也被认为与腹膜炎和超滤失败的发生有关。本研究旨在检测印度的腹膜透析液中是否存在迁移性塑料。

材料与方法

使用液相色谱 - 质谱联用仪(LCMS)和气相色谱 - 质谱联用仪(GCMS)对印度两家制造商生产的腹膜透析液进行检测,采用顶空分析(挥发性化合物)和塑料热解(聚合物化合物)。储存条件和处理方式保持一致。

结果

结果显示存在醋酸盐化合物杂质以及葡萄糖降解产物(GDPs)的醛衍生物,伴有污染物和可浸出塑料。以5 - 羟甲基糠醛化合物(5 - HMF)形式存在的GDP衍生物含量很高。分析还发现存在高浓度的塑料软化剂。

结论

该研究揭示了可能与无菌性腹膜炎和超滤失败发病机制有关的化学物质和GDPs的存在。研究证明了可浸出塑料的存在。总之,在人类使用前,LCMS和GCMS研究可用于检测腹膜透析液中是否存在有害化学物质。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a1f/11763172/466527fadc61/IJN-35-1-34-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a1f/11763172/82ab6767dbca/IJN-35-1-34-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a1f/11763172/b1d40806de48/IJN-35-1-34-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a1f/11763172/466527fadc61/IJN-35-1-34-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a1f/11763172/82ab6767dbca/IJN-35-1-34-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a1f/11763172/b1d40806de48/IJN-35-1-34-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a1f/11763172/466527fadc61/IJN-35-1-34-g3.jpg

相似文献

1
Detections of Chemicals and Migratory Plastics in Peritoneal Dialysis Fluids.腹膜透析液中化学物质和迁移性塑料的检测
Indian J Nephrol. 2025 Jan-Feb;35(1):34-39. doi: 10.25259/ijn_515_23. Epub 2024 Jul 1.
2
The clinical usefulness of peritoneal dialysis fluids with neutral pH and low glucose degradation product concentration: an open randomized prospective trial.具有中性pH值和低糖降解产物浓度的腹膜透析液的临床实用性:一项开放随机前瞻性试验。
Perit Dial Int. 2008 Mar-Apr;28(2):174-82.
3
How to avoid glucose degradation products in peritoneal dialysis fluids.如何避免腹膜透析液中的葡萄糖降解产物。
Perit Dial Int. 2006 Jul-Aug;26(4):490-7.
4
Degradation and de novo formation of nine major glucose degradation products during storage of peritoneal dialysis fluids.储存腹透液期间九种主要葡萄糖降解产物的降解和从头形成。
Sci Rep. 2022 Mar 11;12(1):4268. doi: 10.1038/s41598-022-08123-1.
5
[Biocompatibility of peritoneal dialysis fluids].[腹膜透析液的生物相容性]
Nephrol Ther. 2005 Mar;1(1):14-22. doi: 10.1016/j.nephro.2005.01.005. Epub 2005 Apr 5.
6
Acute inflammation in peritoneal dialysis: experimental studies in rats. Characterization of regulatory mechanisms.腹膜透析中的急性炎症:大鼠实验研究。调节机制的特征
Swed Dent J Suppl. 2005(171):1-57, i.
7
Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (Balance).使用中性pH值和低糖降解产物浓度的腹膜透析液(Balance)治疗的持续性非卧床腹膜透析患者具有更高的生存率。
Perit Dial Int. 2005 May-Jun;25(3):248-55.
8
Biocompatible dialysis fluids for peritoneal dialysis.用于腹膜透析的生物相容性透析液。
Cochrane Database Syst Rev. 2018 Oct 26;10(10):CD007554. doi: 10.1002/14651858.CD007554.pub3.
9
Metal cations promote α-dicarbonyl formation in glucose-containing peritoneal dialysis fluids.金属阳离子促进含葡萄糖的腹膜透析液中α-二羰基化合物的形成。
Glycoconj J. 2021 Jun;38(3):319-329. doi: 10.1007/s10719-020-09964-6. Epub 2020 Dec 7.
10
Rapid and reliable measurement for evaluating directly the reactivity of N-acetylcysteine with glucose degradation products in peritoneal dialysis fluids.快速可靠的测量方法,用于直接评估 N-乙酰半胱氨酸与腹腔透析液中葡萄糖降解产物的反应性。
Anal Chem. 2011 Mar 1;83(5):1518-22. doi: 10.1021/ac200046y. Epub 2011 Feb 7.

本文引用的文献

1
Peritoneal dialysis first policy in Hong Kong for 35 years: Global impact.腹膜透析优先政策在香港实施 35 年:全球影响。
Nephrology (Carlton). 2022 Oct;27(10):787-794. doi: 10.1111/nep.14042. Epub 2022 Apr 13.
2
Degradation and de novo formation of nine major glucose degradation products during storage of peritoneal dialysis fluids.储存腹透液期间九种主要葡萄糖降解产物的降解和从头形成。
Sci Rep. 2022 Mar 11;12(1):4268. doi: 10.1038/s41598-022-08123-1.
3
ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment.
国际腹膜透析学会(ISPD)腹膜炎指南建议:2022年预防与治疗更新版
Perit Dial Int. 2022 Mar;42(2):110-153. doi: 10.1177/08968608221080586.
4
Prevalence of chronic kidney disease in Asia: a systematic review and analysis.亚洲慢性肾脏病的患病率:一项系统评价和分析。
BMJ Glob Health. 2022 Jan;7(1). doi: 10.1136/bmjgh-2021-007525.
5
Peritoneal dialysis: Status report in South and South East Asia.腹膜透析:南亚和东南亚的现状报告。
Nephrology (Carlton). 2021 Nov;26(11):898-906. doi: 10.1111/nep.13949. Epub 2021 Aug 6.
6
Unfavorable Effects of Peritoneal Dialysis Solutions on the Peritoneal Membrane: The Role of Oxidative Stress.腹膜透析液对腹膜的不良影响:氧化应激的作用。
Biomolecules. 2020 May 14;10(5):768. doi: 10.3390/biom10050768.
7
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家慢性肾脏病负担,1990-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2020 Feb 29;395(10225):709-733. doi: 10.1016/S0140-6736(20)30045-3. Epub 2020 Feb 13.
8
Biocompatible dialysis fluids for peritoneal dialysis.用于腹膜透析的生物相容性透析液。
Cochrane Database Syst Rev. 2018 Oct 26;10(10):CD007554. doi: 10.1002/14651858.CD007554.pub3.
9
Biocompatibility of a new PD solution for Japan, Reguneal™, measured as in vitro proliferation of fibroblasts.一种用于日本的新型腹膜透析溶液Reguneal™的生物相容性,通过成纤维细胞的体外增殖来衡量。
Clin Exp Nephrol. 2018 Dec;22(6):1427-1436. doi: 10.1007/s10157-018-1602-2. Epub 2018 Jun 20.
10
The Current State of Peritoneal Dialysis.腹膜透析的现状
J Am Soc Nephrol. 2016 Nov;27(11):3238-3252. doi: 10.1681/ASN.2016010112. Epub 2016 Jun 23.